Provided by Tiger Trade Technology Pte. Ltd.

IN8bio, Inc.

1.40
+0.07005.26%
Post-market: 1.400.00000.00%16:10 EDT
Volume:78.46K
Turnover:112.16K
Market Cap:13.79M
PE:-0.74
High:1.46
Open:1.36
Low:1.36
Close:1.33
52wk High:2.73
52wk Low:0.8800
Shares:9.85M
Float Shares:7.19M
Volume Ratio:0.95
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8935
EPS(LYR):-4.4441
ROE:-111.11%
ROA:-58.37%
PB:0.75
PE(LYR):-0.32

Loading ...

IN8bio CEO Ho Presents at Sidoti Small-Cap Virtual Conference

Reuters
·
Sep 23

IN8bio to Present at Sidoti Small-Cap Virtual Conference

GlobeNewswire
·
Sep 23

IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 10

IN8bio Appoints Oxana Polyakova, Ph.d., as Senior Vice President of Research & Development

THOMSON REUTERS
·
Sep 09

Press Release: IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Dow Jones
·
Sep 09

Mizuho Securities Reaffirms Their Buy Rating on IN8bio (INAB)

TIPRANKS
·
Aug 12

IN8bio Grants New Hire Stock Option for 4,000 Shares Under Inducement Plan

Reuters
·
Aug 11

IN8bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 11

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 11

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Lineage Therap (LCTX) and BioLife Solutions (BLFS)

TIPRANKS
·
Aug 07

IN8bio Q2 EPS $(0.25) Beats $(0.37) Estimate

Benzinga Earnings
·
Aug 07

IN8bio, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 07

Press Release: IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
Aug 07

IN8bio Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 03

IN8bio therapy doubles progression free survival in brain cancer trial

TIPRANKS
·
Jul 09

In8bio Says JCO Publication Shows Inb-200 Trial Doubles Progression-free Survival in Repeat-dose Glioblastoma Patients

Reuters
·
Jul 09

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma

GlobeNewswire
·
Jul 09

Analysts Are Bullish on Top Healthcare Stocks: Corvus Pharmaceuticals (CRVS), IN8bio (INAB)

TIPRANKS
·
Jul 06

IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies

GlobeNewswire
·
Jun 03